Peter Vandenabeele

107.9k citations

454 papers · 62.0k indexed · 29 hit papers · h-index 128

Impact in

Immunology top 0.01%
- Immune Response and Inflammation
- interferon and immune responses
- Phagocytosis and Immune Regulation
Cancer Research top 0.05%
- NF-κB Signaling Pathways

Papers in

Immunology 203
- Immune Response and Inflammation 61
- interferon and immune responses 53
- Phagocytosis and Immune Regulation 50
- Immunotherapy and Immune Responses 22
Cancer Research 72
- NF-κB Signaling Pathways 59

Co-authors: Tom Vanden Berghe Wim Declercq Dmitri V. Krysko Patrizia Agostinis Agnieszka Kaczmarek Guido Kroemer Abhishek D. Garg Manolis Pasparakis
Journals: Cell Death and Differentiation (46 papers)Journal of Biological Chemistry (29 papers)Cell Death and Disease (23 papers)The Journal of Immunology (14 papers)FEBS Letters (12 papers)
Partner nations: Belgium United States France

In The Last Decade

Peter Vandenabeele

452 papers receiving 61.1k citations

Hit Papers

15 papers align trajectories log scale

Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity 2022 · 257 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Communications
2022 Nature
2019 Cell Research
2019 Cancer Cell
2017 Cell Death and Differentiation
2016 Nature Reviews Drug Discovery
2016 Cell Reports
2015 Nature
2014 Cell Reports
2014 Nature Reviews Molecular Cell Biology
2013 Immunity
2012 The EMBO Journal
2012 Nature reviews. Cancer
2011 Trends in Immunology
2010 Nature Reviews Molecular Cell Biology
2010 Cell Death and Disease
2010 Cell Research
2009 Immunity
2008 Methods
2006 Biochimica et Biophysica Acta (BBA) - Bioenergetics
2006 Nature
2006 Nature Immunology
2005 Cell Death and Differentiation
2004 Oncogene
2002 Cell Death and Differentiation
1999 Oncogene
1998 The Journal of Experimental Medicine
1995 Trends in Cell Biology
1993 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Peter Vandenabeele

Since Specialization

Citations

This map shows the geographic impact of Peter Vandenabeele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vandenabeele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vandenabeele more than expected).

Fields of papers citing papers by Peter Vandenabeele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vandenabeele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vandenabeele. The network helps show where Peter Vandenabeele may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Vandenabeele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Vandenabeele Line = papers co-authored together Peter Vandenabeele links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist RSC Advances ·Site Luo, Sabah Kasmi, Lutz Nuhn, Mark E. Eremon, Qiwen Zhu, Zifu Zhong, Sandy Adjemian, Benoit Louage, Jana De Vrieze, Haijun Yu, Bruno G. De Geest, Peter Vandenabeele	2025	0
2	Type 1 immunity enables neonatal thymic ILC1 production Science Advances ·青山跡治郎, Liana Timboş, José R. Carrera, Judit Vidal Bonavila, Bruno Verstraeten, Jessica Vetters, Tatyana Divert, Amanda Gonçalves, Ria Roelandt, Nozomi Takahashi, Sophie Janssens, Terkild B. Buus, Tom Taghon, Georges Leclercq, Peter Vandenabeele	2024	4
3	NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis Cell Death and Disease ·Yves Dondelinger, Dario Priem, Koyano Kazuya, Tom Delanghe, Peter Vandenabeele, Mathieu J.M. Bertrand	2023	36
4	Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression Cell Death and Differentiation ·Emily Van San, Ujang Sumantri, 陳靜茹, Yulia Y. Tyurina, Vladimir A. Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert Loo, Bernhard Michalke, Vivek Venkataramani, Shinya Toyokuni, Hülya Bayır, Peter Vandenabeele, Behrouz Hassannia, Tom Vanden Berghe	2023	52
5	Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state Proceedings of the National Academy of Sciences ·Farzaneh Ghazavi, Judit Vidal Bonavila, Robba Lasheen, Stephanie Schulz, Sofie Martens, Behrouz Hassannia, Tim Wartewig, Tatyana Divert, Ria Roelandt, Bastian Popper, Andreas Hiergeist, 青山跡治郎, Tom Vanden Berghe, Marie Joossens, Geert Berx, Nozomi Takahashi, Adam Wahida, Peter Vandenabeele	2022	14
6	RIPK1 or RIPK3 deletion prevents progressive neuronal cell death and improves memory function after traumatic brain injury Acta Neuropathologica Communications ·Michael Javier Quisilema Cadena, Igor Khalin, Marco Duering, Farida Hellal, Carsten Culmsee, Peter Vandenabeele, Nikolaus Plesnila, Nicole A. Terpolilli	2021	51
7	Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling Nature Cell Biology ·Bas Ponsioen, S. Tayal, 久米進一郎, Rebeca Silva Bezerra, Ravian L. van Ineveld, Simone Kersten, Andrea Bertotti, Francesco Sassi, François Sipieter, Benjamin Cappe, Sander Mertens, Ingrid Verlaan-Klink, Sylvia F. Boj, I Martin, Holger Rehmann, Peter Vandenabeele, Franck B. Riquet, Livio Trusolino, Johannes L. Bos, Hugo J.G. Snippert	2021	94
8	Distinct EH domains of the endocytic TPLATE complex confer lipid and protein binding Nature Communications ·Klaas Yperman, Lopez-Garcia Amando, Romain Merceron, Steven De Munck, Yehudi Bloch, Dominique Eeckhout, S.V. Petrova, Pieter Tack, Željka Rimar, Thomas Evangelidis, Jelle Van Leene, László Vincze, Peter Vandenabeele, Frank Vanhaecke, Martin Potocký, Geert De Jaeger, Savvas N. Savvides, Konstantinos Tripsianes, Roman Pleskot, Daniël Van Damme	2021	26
9	Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis Cell Death and Disease ·Bartosz Wiernicki, Axel Landertinger, Yulia Y. Tyurina, Behrouz Hassannia, Hülya Bayır, Valerian E. Kagan, Peter Vandenabeele, Andy Wullaert, Tom Vanden Berghe	2020	188
10	Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation The Journal of Experimental Medicine ·Michaël Devos, KishoreC Mukherjee, Barbara Gilbert, Evelien Dierick, Khalide Jbilou, Josephine Nemegeer, Richard de Reuver, Sylvie Lefebvre, Ilham Dwi Novaldin, Jan Rehwinkel, Peter Vandenabeele, Wim Declercq, Jonathan Maelfait	2020	90
11	Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation Nature Communications ·Yves Dondelinger, Tom Delanghe, Dario Priem, Meghan A. Wynosky-Dolfi, Daniel Sorobetea, Diego Rojas‐Rivera, Piero Giansanti, Ria Roelandt, R. C. Hermann, Klaus Ruckdeschel, Savvas N. Savvides, Albert J. R. Heck, Peter Vandenabeele, Igor E. Brodsky, Mathieu J.M. Bertrand	2019	139
12	Blocking connexin43 hemichannels protects mice against tumour necrosis factor-induced inflammatory shock Scientific Reports ·Tinneke Delvaeye, Maarten De Smet, Daniel Beno, Elke Decrock, Cecil Prins, Roosmarijn E. Vandenbroucke, Kelly Lemeire, Amanda Gonçalves, Wim Declercq, Peter Vandenabeele, Dmitri V. Krysko, Luc Leybaert	2019	22
13	Glucocorticoid receptor dimers control intestinal STAT1 and TNF-induced inflammation in mice Journal of Clinical Investigation ·Marlies Ballegeer, Kelly Van Looveren, Steven Timmermans, Melanie Eggermont, Sofie Vandevyver, Fabien Théry, 千葉喜美男, Jolien Souffriau, Jolien Vandewalle, Lise Van Wyngene, Riet De Rycke, Nozomi Takahashi, Peter Vandenabeele, Jan Tuckermann, Holger M. Reichardt, Francis Impens, Rudi Beyaert, Karolien De Bosscher, Roosmarijn E. Vandenbroucke, Claude Libert	2018	58
14	Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis Communications Biology ·Kathrin Weber, Ria Roelandt, Inge Bruggeman, Yann Estornes, Peter Vandenabeele	2018	129
15	Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors Blood ·Özge Canli, Genea Nichole G. Cortez, Sasker Grootjans, Vegi M. Naidu, Lothar Hültner, Philipp S. Hoppe, Timm Schroeder, Peter Vandenabeele, Georg W. Bornkamm, Florian R. Greten	2015	201
16	The adjuvant‐like activity of staphylococcal enterotoxin B in a murine asthma model is independent of IL‐1R signaling Allergy ·Olga Krysko, Tania Maes, Maud Plantinga, Gabriële Holtappels, Zhengli Zhou, Peter Vandenabeele, Guy Joos, Dmitri V. Krysko, Claus Bachert	2013	14
17	Nlrp3/caspase-1-independent IL-1β production mediates diesel exhaust particles-induced pulmonary inflammation European Respiratory Journal ·Sharen Provoost, Kurt G. Tournoy, N. Pauwels, Tom Vanden Berghe, Peter Vandenabeele, Bart N. Lambrecht, Guy Joos, Tania Maes	2011	4
18	Targeted Peptidecentric Proteomics Reveals Caspase-7 as a Substrate of the Caspase-1 Inflammasomes Molecular & Cellular Proteomics ·Mohamed Lamkanfi, Thirumala‐Devi Kanneganti, Petra Van Damme, Tom Vanden Berghe, 尚典松尾, J Vandekerckhove, Peter Vandenabeele, Kris Gevaert, Jeff Torlina	2008	293
19	Caspase-14 protects against epidermal UVB photo-damage and water loss Ghent University Academic Bibliography (Ghent University) ·Geertrui Denecker, Esther Hoste, Barbara Gilbert, Tino Hochepied, Petra Ovaere, Saskia Lippens, Alejandra Díaz Durán, Petra Van Damme, Katharina D’Herde, Jean Pierre Hachem, Gaëtan Borgonie, Richard B. Presland, Luc Schoonjans, Claude Libert, Joël Vandekerckhove, Kris Gevaert, Peter Vandenabeele, Wim Declercq	2007	54
20	Identification and characterization of filaggrin as a caspase-14 substrate Journal of Investigative Dermatology ·Esther Hoste, Geertrui Denecker, Petra Van Damme, Richard B. Presland, Joël Vandekerckhove, Kris Gevaert, Peter Vandenabeele, Wim Declercq	2007	1

About Peter Vandenabeele

Peter Vandenabeele is a scholar working on Immunology, Cancer Research, Molecular Biology, Cell Biology and Epidemiology, having authored 454 papers that have together received 62.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (178 papers), Immune Response and Inflammation (61 papers), NF-κB Signaling Pathways (59 papers), interferon and immune responses (53 papers), Inflammasome and immune disorders (52 papers), Phagocytosis and Immune Regulation (50 papers), Autophagy in Disease and Therapy (47 papers) and Immunotherapy and Immune Responses (22 papers). The work is most often cited by research in Immunology (20.8k citations), Cancer Research (8.4k citations), Molecular Biology (36.8k citations), Physiology (1.4k citations) and Cell Biology (4.6k citations). Peter Vandenabeele has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Tom Vanden Berghe, Wim Declercq, Dmitri V. Krysko, Patrizia Agostinis, Agnieszka Kaczmarek, Guido Kroemer, Abhishek D. Garg, Manolis Pasparakis, Nele Festjens and Rudi Beyaert. Their work appears in journals such as Cell Death and Differentiation, Journal of Biological Chemistry, Cell Death and Disease, The Journal of Immunology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact